VIVOS THERAPEUTICS INC (VVOS)

US92859E2072 - Common Stock

4.25  -0.04 (-0.93%)

VIVOS THERAPEUTICS INC

NASDAQ:VVOS (1/2/2025, 8:01:37 PM)

4.25

-0.04 (-0.93%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustryHealth Care Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%75.31%
Sales Q2Q%16.93%
CRS67.24
6 Month84.78%
Overview
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Ins Owners1.53%
Inst Owners12.54%
Market Cap20.57M
Shares4.84M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.5
Short Float %3.11%
Short Ratio0.72
IPO12-11 2020-12-11
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

VVOS Daily chart

Company Profile

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 114 full-time employees. The company went IPO on 2020-12-11. The firm calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.

Company Info

VIVOS THERAPEUTICS INC

7921 Southpark Plaza,, Suite 210

Littleton COLORADO

P: 18669084867

Employees: 119

Website: https://vivos.com/

VVOS News

News Image11 days ago - Vivos Therapeutics, IncVivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules...

News Image23 days ago - TheNewswire.comWater Tower Research Publishes Initiation of Coverage Report on Vivos Therapeutics, Inc., “New Strategic Model & Key Regulatory Milestones Provide Revenue Tailwind”

December 10, 2024, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Vivos Therapeutics, Inc. (NASDAQ: VVOS) titled, “New Strategic Model & Key Regulatory Milestones Provide Revenue Tailwind.” The report can be accessed here.

News Image2 months ago - Vivos Therapeutics, IncVivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo.,...

News Image2 months ago - Vivos Therapeutics, IncVivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Call Scheduled for Thursday, November 14, 2024 at 5:00 pm ET...

News Image3 months ago - InvezzInvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
News Image3 months ago - Vivos Therapeutics, IncVivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

New Medical Codes will Facilitate Billing by Commercial Payers for Vivos CARE Treatment for Obstructive Sleep Apnea in Adults and Children...

VVOS Twits

Here you can normally see the latest stock twits on VVOS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example